Skip to main page content

dbSNP Short Genetic Variations

Reference SNP (rs) Report


This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.


Current Build 151

Released July 17, 2018

Homo sapiens
chr11:113412966 (GRCh38.p7) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Variation Type
SNV Single Nucleotide Variation
A=0.16976 (21317/125568, TOPMED)
A=0.1705 (5264/30868, GnomAD)
A=0.230 (1150/5008, 1000G) (+ 2 more)
A=0.146 (563/3854, ALSPAC)
A=0.156 (577/3708, TWINSUK)
Clinical Significance
Reported in ClinVar
Gene : Consequence
DRD2 : Intron Variant
62 citations
Genomic View
See rs on genome

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p7 chr 11 NC_000011.10:g.113412966C>A
GRCh37.p13 chr 11 NC_000011.9:g.113283688C>A
DRD2 RefSeqGene NG_008841.1:g.67314G>T
Gene: DRD2, dopamine receptor D2 (minus strand)
Molecule type Change Amino acid[Codon] SO Term
DRD2 transcript variant 1 NM_000795.3:c. N/A Intron Variant
DRD2 transcript variant 2 NM_016574.3:c. N/A Intron Variant
DRD2 transcript variant X1 XM_017017296.1:c. N/A Intron Variant

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: A (allele ID: 362504 )
ClinVar Accession Disease Names Clinical Significance
RCV000417152.1 cocaine response - Toxicity/ADR Drug-Response
RCV000630731.1 Dystonia Likely-Benign

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Study Population Group Sample Size Ref Allele Alt Allele
Trans-Omics for Precision Medicine Global Study-wide 125568 C=0.83024 A=0.16976
The Genome Aggregation Database Global Study-wide 30868 C=0.8295 A=0.1705
The Genome Aggregation Database European Sub 18444 C=0.8227 A=0.1773
The Genome Aggregation Database African Sub 8694 C=0.908 A=0.092
The Genome Aggregation Database East Asian Sub 1616 C=0.585 A=0.415
The Genome Aggregation Database Other Sub 976 C=0.80 A=0.20
The Genome Aggregation Database American Sub 836 C=0.65 A=0.35
The Genome Aggregation Database Ashkenazi Jewish Sub 302 C=0.88 A=0.12
1000Genomes Global Study-wide 5008 C=0.770 A=0.230
1000Genomes African Sub 1322 C=0.917 A=0.083
1000Genomes East Asian Sub 1008 C=0.584 A=0.416
1000Genomes Europe Sub 1006 C=0.850 A=0.150
1000Genomes South Asian Sub 978 C=0.71 A=0.29
1000Genomes American Sub 694 C=0.73 A=0.27
The Avon Longitudinal Study of Parents and Children PARENT AND CHILD COHORT Study-wide 3854 C=0.854 A=0.146
UK 10K study - Twins TWIN COHORT Study-wide 3708 C=0.844 A=0.156

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement C= A Note
GRCh38.p7 chr 11 NC_000011.10:g.113412966C= NC_000011.10:g.11341296...


GRCh37.p13 chr 11 NC_000011.9:g.113283688C= NC_000011.9:g.113283688C>A
DRD2 RefSeqGene NG_008841.1:g.67314G= NG_008841.1:g.67314G>T

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

2 ClinVar, 68 SubSNP, 5 Frequency submissions
No Submitter Submission ID Date (Build)
1 TSC-CSHL ss90383 Oct 13, 2000 (86)
2 HGBASE ss2420601 Nov 14, 2000 (92)
3 SC_JCM ss3636626 Sep 28, 2001 (100)
4 SNP500CANCER ss5586475 Mar 31, 2003 (113)
5 WI_SSAHASNP ss6829735 Feb 20, 2003 (111)
6 SC_SNP ss15496920 Feb 27, 2004 (120)
7 ABI ss38668270 Mar 14, 2006 (126)
8 ILLUMINA ss75009419 Dec 06, 2007 (129)
9 CGM_KYOTO ss76867035 Dec 06, 2007 (129)
10 CNG ss95211012 Mar 25, 2008 (129)
11 SHGC ss99307683 Feb 06, 2009 (130)
12 BGI ss103002138 Dec 01, 2009 (131)
13 1000GENOMES ss111100713 Jan 25, 2009 (130)
14 KRIBB_YJKIM ss119381898 Dec 01, 2009 (131)
15 ILLUMINA ss159917227 Dec 01, 2009 (131)
16 ILLUMINA ss170483112 Jul 04, 2010 (132)
17 BUSHMAN ss203228089 Jul 04, 2010 (132)
18 1000GENOMES ss225469640 Jul 14, 2010 (132)
19 1000GENOMES ss235724792 Jul 15, 2010 (132)
20 1000GENOMES ss242321872 Jul 15, 2010 (132)
21 ILLUMINA ss244269984 Jul 04, 2010 (132)
22 GMI ss281176567 May 04, 2012 (137)
23 PJP ss291142855 May 09, 2011 (134)
24 ILLUMINA ss479338264 May 04, 2012 (137)
25 ILLUMINA ss479341318 May 04, 2012 (137)
26 ILLUMINA ss479734913 Sep 08, 2015 (146)
27 ILLUMINA ss484469327 May 04, 2012 (137)
28 TISHKOFF ss562835394 Apr 25, 2013 (138)
29 SSMP ss658358432 Apr 25, 2013 (138)
30 ILLUMINA ss782681226 Sep 08, 2015 (146)
31 ILLUMINA ss831932010 Sep 08, 2015 (146)
32 EVA-GONL ss988978354 Aug 21, 2014 (142)
33 JMKIDD_LAB ss1078056554 Aug 21, 2014 (142)
34 1000GENOMES ss1343024686 Aug 21, 2014 (142)
35 DDI ss1426765559 Apr 01, 2015 (144)
36 EVA_GENOME_DK ss1575961572 Apr 01, 2015 (144)
37 EVA_DECODE ss1598644376 Apr 01, 2015 (144)
38 EVA_UK10K_ALSPAC ss1627494383 Apr 01, 2015 (144)
39 EVA_UK10K_TWINSUK ss1670488416 Apr 01, 2015 (144)
40 EVA_MGP ss1711309126 Apr 01, 2015 (144)
41 EVA_SVP ss1713285867 Apr 01, 2015 (144)
42 ILLUMINA ss1751995138 Sep 08, 2015 (146)
43 WEILL_CORNELL_DGM ss1932339499 Feb 12, 2016 (147)
44 ILLUMINA ss1959386590 Feb 12, 2016 (147)
45 GENOMED ss1967462521 Jul 19, 2016 (147)
46 JJLAB ss2026913647 Sep 14, 2016 (149)
47 USC_VALOUEV ss2155226183 Dec 20, 2016 (150)
48 HUMAN_LONGEVITY ss2185829458 Dec 20, 2016 (150)
49 TOPMED ss2349419913 Dec 20, 2016 (150)
50 SYSTEMSBIOZJU ss2627931658 Nov 08, 2017 (151)
51 ILLUMINA ss2632889071 Nov 08, 2017 (151)
52 GRF ss2699536345 Nov 08, 2017 (151)
53 GNOMAD ss2904624365 Nov 08, 2017 (151)
54 AFFY ss2984957621 Nov 08, 2017 (151)
55 AFFY ss2985599051 Nov 08, 2017 (151)
56 SWEGEN ss3008803639 Nov 08, 2017 (151)
57 ILLUMINA ss3021377298 Nov 08, 2017 (151)
58 BIOINF_KMB_FNS_UNIBA ss3027257499 Nov 08, 2017 (151)
59 TOPMED ss3156777688 Nov 08, 2017 (151)
60 CSHL ss3349801602 Nov 08, 2017 (151)
61 ILLUMINA ss3633699835 Jul 20, 2018 (151)
62 ILLUMINA ss3634475982 Jul 20, 2018 (151)
63 ILLUMINA ss3635391110 Jul 20, 2018 (151)
64 ILLUMINA ss3636160277 Jul 20, 2018 (151)
65 ILLUMINA ss3637142013 Jul 20, 2018 (151)
66 ILLUMINA ss3637931200 Jul 20, 2018 (151)
67 ILLUMINA ss3640183318 Jul 20, 2018 (151)
68 ILLUMINA ss3642927610 Jul 20, 2018 (151)
69 1000Genomes NC_000011.9 - 113283688 Jul 20, 2018 (151)
70 The Avon Longitudinal Study of Parents and Children NC_000011.9 - 113283688 Jul 20, 2018 (151)
71 The Genome Aggregation Database NC_000011.9 - 113283688 Jul 20, 2018 (151)
72 Trans-Omics for Precision Medicine NC_000011.10 - 113412966 Jul 20, 2018 (151)
73 UK 10K study - Twins NC_000011.9 - 113283688 Jul 20, 2018 (151)
74 ClinVar RCV000417152.1 Jul 20, 2018 (151)
75 ClinVar RCV000630731.1 Jul 20, 2018 (151)

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs1800500 Jan 18, 2001 (92)
Added to this RefSNP Cluster:
Submission ids Observation SPDI Canonical SPDI Source RSIDs
ss111100713, ss203228089, ss281176567, ss291142855, ss479338264, ss1598644376, ss1713285867, ss3642927610 NC_000011.8:112788897:C= NC_000011.10:113412965:C= (self)
55609119, 30866859, 38325887, 30866859, ss225469640, ss235724792, ss242321872, ss479341318, ss479734913, ss484469327, ss562835394, ss658358432, ss782681226, ss831932010, ss988978354, ss1078056554, ss1343024686, ss1426765559, ss1575961572, ss1627494383, ss1670488416, ss1711309126, ss1751995138, ss1932339499, ss1959386590, ss1967462521, ss2026913647, ss2155226183, ss2349419913, ss2627931658, ss2632889071, ss2699536345, ss2904624365, ss2984957621, ss2985599051, ss3008803639, ss3021377298, ss3349801602, ss3633699835, ss3634475982, ss3635391110, ss3636160277, ss3637142013, ss3637931200, ss3640183318 NC_000011.9:113283687:C= NC_000011.10:113412965:C= (self)
72749336, ss2185829458, ss3027257499, ss3156777688 NC_000011.10:113412965:C= NC_000011.10:113412965:C= (self)
ss15496920 NT_033899.6:16827473:C= NC_000011.10:113412965:C= (self)
ss90383, ss2420601, ss3636626, ss5586475, ss6829735, ss38668270, ss75009419, ss76867035, ss95211012, ss99307683, ss103002138, ss119381898, ss159917227, ss170483112, ss244269984 NT_033899.8:16846103:C= NC_000011.10:113412965:C= (self)
ss111100713, ss203228089, ss281176567, ss291142855, ss479338264, ss1598644376, ss1713285867, ss3642927610 NC_000011.8:112788897:C>A NC_000011.10:113412965:C>A (self)
55609119, 30866859, 38325887, 30866859, ss225469640, ss235724792, ss242321872, ss479341318, ss479734913, ss484469327, ss562835394, ss658358432, ss782681226, ss831932010, ss988978354, ss1078056554, ss1343024686, ss1426765559, ss1575961572, ss1627494383, ss1670488416, ss1711309126, ss1751995138, ss1932339499, ss1959386590, ss1967462521, ss2026913647, ss2155226183, ss2349419913, ss2627931658, ss2632889071, ss2699536345, ss2904624365, ss2984957621, ss2985599051, ss3008803639, ss3021377298, ss3349801602, ss3633699835, ss3634475982, ss3635391110, ss3636160277, ss3637142013, ss3637931200, ss3640183318 NC_000011.9:113283687:C>A NC_000011.10:113412965:C>A (self)
RCV000417152.1, RCV000630731.1, 72749336, ss2185829458, ss3027257499, ss3156777688 NC_000011.10:113412965:C>A NC_000011.10:113412965:C>A (self)
ss15496920 NT_033899.6:16827473:C>A NC_000011.10:113412965:C>A (self)
ss90383, ss2420601, ss3636626, ss5586475, ss6829735, ss38668270, ss75009419, ss76867035, ss95211012, ss99307683, ss103002138, ss119381898, ss159917227, ss170483112, ss244269984 NT_033899.8:16846103:C>A NC_000011.10:113412965:C>A (self)

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

62 citations for rs1076560
PMID Title Author Year Journal
17196743 Association analysis of the dopamine receptor D2 (DRD2) SNP rs1076560 in alcoholic patients. Sasabe T et al. 2007 Neuroscience letters
18077373 Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Zhang Y et al. 2007 Proceedings of the National Academy of Sciences of the United States of America
18829695 Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. Bertolino A et al. 2009 Brain
19176830 Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. Bertolino A et al. 2009 The Journal of neuroscience
19321766 Dopamine DRD2 polymorphism alters reversal learning and associated neural activity. Jocham G et al. 2009 The Journal of neuroscience
19373123 Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution. Doehring A et al. 2009 Pharmacogenetics and genomics
19393722 Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphisms. Frank MJ et al. 2009 Neuroscience
19512960 Genetic diagnostics of functional variants of the human dopamine D2 receptor gene. Doehring A et al. 2009 Psychiatric genetics
19796663 Influence of DRD2 and ANKK1 genotypes on apomorphine-induced growth hormone (GH) response in alcohol-dependent patients. Lucht M et al. 2010 Progress in neuro-psychopharmacology & biological psychiatry
19940176 Functional variation of the dopamine D2 receptor gene is associated with emotional control as well as brain activity and connectivity during emotion processing in humans. Blasi G et al. 2009 The Journal of neuroscience
20146828 Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study. Prasad P et al. 2010 BMC medical genetics
20179754 Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance. Bertolino A et al. 2010 PloS one
20617039 Alcoholism and alternative splicing of candidate genes. Sasabe T et al. 2010 International journal of environmental research and public health
20736885 PharmGKB summary: dopamine receptor D2. Mi H et al. 2011 Pharmacogenetics and genomics
20881944 The roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humans. Rogers RD et al. 2011 Neuropsychopharmacology
20934307 The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions. Baharnoori M et al. 2010 Schizophrenia research
21087673 D2 receptor genotype and striatal dopamine signaling predict motor cortical activity and behavior in humans. Fazio L et al. 2011 NeuroImage
21150907 Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Moyer RA et al. 2011 Neuropsychopharmacology
21187413 DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia. Blasi G et al. 2011 Proceedings of the National Academy of Sciences of the United States of America
21289622 Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy. Sadee W et al. 2011 Clinical pharmacology and therapeutics
21438146 Dysfunctional gene splicing as a potential contributor to neuropsychiatric disorders. Glatt SJ et al. 2011 American journal of medical genetics. Part B, Neuropsychiatric genetics
21527290 Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood. Nemoda Z et al. 2011 Neuroscience and biobehavioral reviews
21645585 Resting posterior minus frontal EEG slow oscillations is associated with extraversion and DRD2 genotype. Koehler S et al. 2011 Biological psychology
21948099 Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential? Blum K et al. 2011 Molecular neurobiology
21976709 DRD2 genotype-based variation of default mode network activity and of its relationship with striatal DAT binding. Sambataro F et al. 2013 Schizophrenia bulletin
22102315 Strong protective effect of the aldehyde dehydrogenase gene (ALDH2) 504lys (*2) allele against alcoholism and alcohol-induced medical diseases in Asians. Li D et al. 2012 Human genetics
22424959 DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience. PeciƱa M et al. 2013 Cortex; a journal devoted to the study of the nervous system and behavior
22529823 Connectomic intermediate phenotypes for psychiatric disorders. Fornito A et al. 2012 Frontiers in psychiatry
22559203 DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families. Hettinger JA et al. 2012 Behavioral and brain functions
22569179 Rs1076560, a functional variant of the dopamine D2 receptor gene, confers risk of schizophrenia in Han Chinese. Zheng C et al. 2012 Neuroscience letters
22745721 Cannabis-dependence risk relates to synergism between neuroticism and proenkephalin SNPs associated with amygdala gene expression: case-control study. Jutras-Aswad D et al. 2012 PloS one
22829935 Acyl coenzyme A synthetase long-chain 1 (ACSL1) gene polymorphism (rs6552828) and elite endurance athletic status: a replication study. Yvert T et al. 2012 PloS one
22963930 Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent. Al-Eitan LN et al. 2012 BMC research notes
22992668 Pharmacogenomics knowledge for personalized medicine. Whirl-Carrillo M et al. 2012 Clinical pharmacology and therapeutics
23097719 Current perspectives on the neurobiology of drug addiction: a focus on genetics and factors regulating gene expression. Duncan JR et al. 2012 ISRN neurology
23340505 Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction. Sullivan D et al. 2013 Translational psychiatry
24322206 Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain. Kaalund SS et al. 2014 Molecular psychiatry
24359476 The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction. Clarke TK et al. 2014 Annals of human genetics
24410775 Moderator effects of working memory on the stability of ADHD symptoms by dopamine receptor gene polymorphisms during development. Trampush JW et al. 2014 Developmental science
24424781 DRD2 genotype predicts prefrontal activity during working memory after stimulation of D2 receptors with bromocriptine. Gelao B et al. 2014 Psychopharmacology
24782743 Association of COMT and COMT-DRD2 interaction with creative potential. Zhang S et al. 2014 Frontiers in human neuroscience
24819610 DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory. Di Giorgio A et al. 2014 PloS one
24944790 Screening for 392 polymorphisms in 141 pharmacogenes. Kim JY et al. 2014 Biomedical reports
25563748 Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics. Blasi G et al. 2015 Neuropsychopharmacology
25819021 A review of pharmacogenetic studies of substance-related disorders. Jones JD et al. 2015 Drug and alcohol dependence
25829376 Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis. Colizzi M et al. 2015 Schizophrenia bulletin
26044620 Gene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction. Reyes-Gibby CC et al. 2015 BMC systems biology
26347318 A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples. Cohen OS et al. 2016 Molecular psychiatry
26642826 Network-Dependent Modulation of COMT and DRD2 Polymorphisms in Healthy Young Adults. Zhao F et al. 2015 Scientific reports
26658939 Hnrnph1 Is A Quantitative Trait Gene for Methamphetamine Sensitivity. Yazdani N et al. 2015 PLoS genetics
26926883 Genetic variation and dopamine D2 receptor availability: a systematic review and meta-analysis of human in vivo molecular imaging studies. Gluskin BS et al. 2016 Translational psychiatry
27190009 Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study. Masellis M et al. 2016 Brain
27446594 Genotype frequencies for polymorphisms related to chemotherapy-induced nausea and vomiting in a Japanese population. Goto A et al. 2016 Journal of pharmaceutical health care and sciences
27848079 Cabergoline and prolactinomas: lack of association between DRD2 polymorphisms and response to treatment. Bueno C et al. 2017 Pituitary
27867061 Interaction between DRD2 variation and sound environment on mood and emotion-related brain activity. Quarto T et al. 2017 Neuroscience
27895608 Genetic Consideration of Schizotypal Traits: A Review. Walter EE et al. 2016 Frontiers in psychology
27933030 The Association of <i>DRD2</i> with Insight Problem Solving. Zhang S et al. 2016 Frontiers in psychology
28104410 The DRD2 rs1076560 polymorphism and schizophrenia-related intermediate phenotypes: A systematic review and meta-analysis. Luykx JJ et al. 2017 Neuroscience and biobehavioral reviews
28692418 Contribution of Genetic Polymorphisms and Haplotypes in DRD2, BDNF, and Opioid Receptors to Heroin Dependence and Endophenotypes Among the Han Chinese. Gao X et al. 2017 Omics
28798405 Progress in genome-wide association studies of schizophrenia in Han Chinese populations. Yue W et al. 2017 NPJ schizophrenia
29042896 Genome-Wide Supported Risk Variants in <i>MIR137</i>, <i>CACNA1C</i>, <i>CSMD1</i>, <i>DRD2</i>, and <i>GRM3</i> Contribute to Schizophrenia Susceptibility in Pakistani Population. Fatima A et al. 2017 Psychiatry investigation
29249680 Dopaminergic polymorphisms associated with medication responsiveness of gait in Parkinson's disease. Miller NS et al. 2018 Parkinsonism & related disorders

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 0.1.4.post833+d3ba21e